$12.19
-0.53-4.17%
At close: Jun 16, 5:00 PM EST
$12.20
0.010.08%
After Hours: 4:38 PM EST
Core Laboratories Inc Stock Guidance
CLBNYSE
Core Laboratories (CLB) last issued guidance on April 29, 2026 for Q2 2026. The company guided earnings per share in the range of $0.06 - $0.12, compared to a consensus EPS estimate of $0.15. Core Laboratories also guided revenue in the range of $123.00M - $131.00M for the period.
Compared to prior guidance, Core Laboratories raised its revenue forecast from a prior range of $119.00M - $123.00M.
Core Laboratories has issued 17 guidance updates between July 27, 2022 and April 29, 2026. During this period, the company raised its outlook 6 times and lowered it 8 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
Apr 29, 2026
Guidance Period
Q2 2026
EPS Guidance Range
$0.06 - $0.12
Revenue Guidance Range
$123.00M - $131.00M
Core Laboratories Guidance History
Review all historical guidance issued by Core Laboratories, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Core Laboratories (CLB)?
The most recent guidance for Core Laboratories (CLB) was reported on April 29, 2026 for Q2 2026. The company provided earnings per share guidance in the range of $0.06 to $0.12, compared to the estimated EPS of $0.15. Additionally, Core Laboratories forecasted revenue between $123.00M and $131.00M for the period.
What EPS range did Core Laboratories (CLB) guide for?
Core Laboratories (CLB) guided EPS in the range of $0.06 to $0.12 for Q2 2026. The consensus analyst EPS estimate is $0.15.
What revenue range did Core Laboratories (CLB) guide for?
Core Laboratories (CLB) guided revenue in the range of $123.00M to $131.00M for Q2 2026.
Did Core Laboratories (CLB) raise or lower guidance?
Core Laboratories (CLB) raised its revenue guidance from a prior range of $119.00M - $123.00M to $123.00M - $131.00M for Q2 2026.
When did Core Laboratories (CLB) last issue guidance?
Core Laboratories (CLB) last issued guidance on April 29, 2026 for Q2 2026.
